Adicet Bio (ACET) Receivables (2020 - 2022)

Adicet Bio's Receivables history runs 3 years deep, the most recent figure standing at $359000.0 for Q3 2022.

• In Q3 2022, Receivables changed N/A year-over-year to $359000.0; the TTM figure through Sep 2022 stood at $359000.0 (changed N/A YoY), while the FY2021 annual figure was $229000.0, up 895.65% from the prior year.
• Receivables for Q3 2022 stood at $359000.0, up from $229000.0 in the prior quarter.
• The five-year high for Receivables was $10.0 million in Q2 2020, with the low at $23000.0 in Q4 2020.
• The 3-year median for Receivables is $229000.0 (2021), against an average of $2.1 million.
• Peak annual rise in Receivables reached 895.65% in 2021, while the deepest fall reached 895.65% in 2021.
• Adicet Bio's Receivables stood at $23000.0 in 2020, then jumped by 895.65% to $229000.0 in 2021, then jumped by 56.77% to $359000.0 in 2022.
• Business Quant data shows ACET's Receivables at $359000.0 in Q3 2022, $229000.0 in Q4 2021, and $23000.0 in Q4 2020.